 - Use of anticoagulants e.g., warfarin, heparin at therapeutic levels within 7 days prior to the first dose of GSK525762. Low dose prophylactic low molecular weight heparin LMWH is permitted. In addition, INR must be monitored in accordance with local institutional practices, as appropriate. 